It is Sunday evening, and Thursday’s board pack runs to 140 pages. You have read packs like it for years. This time you paste the two longest appendices into a chatbot and ask what you should be worried about. It returns five issues in 90 seconds. Two of them are worth considering. On Thursday you raise both, and the discussion is productive.
Nobody in the room knows you used AI to go through the pack. Nothing you did was against any rule. And no one, including you, can say what the model left out.
You are not unusual. A June 2026 survey by Diligent Institute and Corporate Board Member found that 82% of 104 US public-company directors had used generative AI in board work in the previous six months, up from 66% nine months earlier. While board members have access to confidential information, only 6% of people surveyed reported an AI policy specific to the board. Diligent sells board software, and the panel is small, so read this as direction.
I have spent more than a decade examining how boards make oversight visible: the papers they receive, the questions they ask, what ends up in the minutes. But ask a chair what their board’s AI policy covers, and you usually get the company’s AI policy. Boards are governing the use of technology for the organization but not monitoring their own use of it.
This oversight stems from a fundamental error: boards focus on approving tools – which portal, which AI assistant, which vendor. This is a misguided approach: a tool is cleared once and then does many different jobs, and those jobs contain various levels of risk. For example, a director may use the same tool to summarize a paper or select risks for discussion, but those uses require different checks. Approving a use defines how far the board will rely on what comes back.
Boards must approve the use, not the tool. And to do that, they need a way to distinguish those uses before relying on the same tool for different tasks.